Stockreport

IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer

IN8bio, Inc.  (INAB) 
PDF NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- IN8bio (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (?d ) T cell therapies [Read more]